Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04418817 · ClinicalTrials.gov registry record
Modulus in XLIF Study
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 36
- Enrollment target
NCT04418817 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 36 participants.
The verdict
NCT04418817 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and performance of the Modulus 3D-printed titanium interbody implant in patients undergoing thoracic and/or lumbar XLIF as measured by reported complications, radiographic outcomes, and patient-reported outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2020-03-22 |
| Est. Completion | 2024-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04418817
The ClinicalTrials.gov registry entry for NCT04418817 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04418817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04418817 about?
NCT04418817 is a clinical study titled "Modulus in XLIF Study". The primary objective of this study is to evaluate the safety and performance of the Modulus 3D-printed titanium interbody implant in patients undergoing thoracic and/or lumbar XLIF as measured by reported complications, radiographic outcomes, and patient-reported outcomes.
What is the current status of trial NCT04418817?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2020-03-22. Estimated completion is 2024-01-31.
Who is sponsoring clinical trial NCT04418817?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.